Cancer associated fibroblasts have phenotypic and functional characteristics similar to the fibrocytes that represent a novel MDSC subset

OncoImmunology

Volumn 4, Issue 9, 2015, Pages 1-9

  Gunaydin, Gurcan ^a   Kesikli, S Altug ^a   Guc, Dicle ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Breast cancer; Chemical carcinogenesis; Fibroblast; T cell; Tumor immunity

Indexed keywords

B7 ANTIGEN; INTERLEUKIN 4; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; SEPRASE; VIMENTIN;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ISOLATION; CELL POPULATION; CELL PROLIFERATION; CONTROLLED STUDY; FEMALE; FIBROBLAST; FLOW CYTOMETRY; GENE EXPRESSION; GENETIC ANALYSIS; IMMUNOCYTOCHEMISTRY; IMMUNOMODULATION; IMMUNOSUPPRESSIVE TREATMENT; MYELOID DERIVED SUPPRESSOR CEL; NONHUMAN; PHENOTYPE; RAT; SUPPRESSOR CELL; TUMOR MICROENVIRONMENT;

EID: 84944451897     PISSN: 21624011     EISSN: 2162402X     Source Type: Journal    
DOI: 10.1080/2162402X.2015.1034918     Document Type: Article

References (79)

1. Gabrilovich DI, Nagaraj S. Myeloid-derived suppressor cells as regulators of the immune system. Nat Rev Immunol 2009; 9:162-74; PMID:19197294; http:// dx.doi.org/10.1038/nri2506
2. Senovilla L, Aranda F, Galluzzi L, Kroemer G. Impact of myeloid cells on the efficacy of anticancer chemotherapy. Curr Opin Immunol 2014; 30C:24-31; PMID:24950 501; http://dx.doi.org/10.1016/j.coi.2014.05.009
3. Bronte V, Wang M, Overwijk WW, Surman DR, Pericle F, Rosenberg SA, Restifo NP. Apoptotic death of CD8+ T lymphocytes after immunization: induction of a suppressive population of Mac-1C/Gr-1C cells. J Immunol 1998; 161:5313-20; PMID:9820504
4. Youn JI, Nagaraj S, CollazoM, Gabrilovich DI. Subsets of myeloid-derived suppressor cells in tumor-bearing mice. J Immunol 2008; 181:5791-802; PMID:18832739; http:// dx.doi.org/10.4049/jimmunol.181.8.5791
5. Prins RM, Scott GP, Merchant RE, Graf MR. Irradiated tumor cell vaccine for treatment of an established glioma. II. Expansion of myeloid suppressor cells that promote tumor progression. Cancer Immunol, Immunother 2002; 51:190-9; PMID:12012106; http://dx.doi.org/10.1007/s00262-002-0270-x
6. Almand B, Clark JI, Nikitina E, van Beynen J, EnglishNR, Knight SC, Carbone DP, Gabrilovich DI. Increased production of immature myeloid cells in cancer patients: a mechanism of immunosuppression in cancer. J Immunol 2001; 166:678-89; PMID:11123353; http://dx.doi.org/ 10.4049/jimmunol.166.1.678
7. Ochoa AC, Zea AH, Hernandez C, Rodriguez PC. Arginase, prostaglandins, and myeloid-derived suppressor cells in renal cell carcinoma. Clin Cancer Res 2007; 13:721s-6s; PMID:17255300; http://dx.doi.org/ 10.1158/1078-0432.CCR-06-2197
8. Schreiber RD, Old LJ, Smyth MJ. Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion. Science 2011; 331:1565-70; PMID:21436444; http://dx.doi.org/10.1126/science. 1203486
9. Zitvogel L, Tesniere A, Kroemer G. Cancer despite immunosurveillance: immunoselection and immunosubversion. Nat Rev Immunol 2006; 6:715-27; PMID:16977338; http://dx.doi.org/10.1038/nri1936
10. Zitvogel L, Tanchot C, Granier C, Tartour E. Following up tumor-specific regulatory T cells in cancer patients. Oncoimmunology 2013; 2:e25444; PMID:24073383; http://dx.doi.org/10.4161/onci.25444
11. Pietras K, Ostman A. Hallmarks of cancer: interactions with the tumor stroma. Exp Cell Res 2010; 316:1324-31; PMID:20211171; http://dx.doi.org/10.1016/j. yexcr.2010.02.045
12. Kalluri R, Zeisberg M. Fibroblasts in cancer. Nat Rev Cancer 2006; 6:392-401; PMID:16572188; http://dx. doi.org/10.1038/nrc1877
13. Sappino AP, Skalli O, Jackson B, Schurch W, Gabbiani G. Smooth-muscle differentiation in stromal cells of malignant and non-malignant breast tissues. Int J Cancer 1988; 41:707-12; PMID:2835323; http://dx.doi. org/10.1002/ijc.2910410512
14. Dvorak HF. Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. N Engl J Med 1986; 315:1650-9; PMID:3537791; http://dx.doi.org/10.1056/NEJM198612253152606
15. Schauer IG, Sood AK, Mok S, Liu J. Cancer-associated fibroblasts and their putative role in potentiating the initiation and development of epithelial ovarian cancer. Neoplasia 2011; 13:393-405; PMID:21532880; http://dx.doi.org/10.1593/neo.101720
16. Kharaziha P, Rodriguez P, Li Q, Rundqvist H, Bjorklund AC, Augsten M, Ullen A, Egevad L, Wiklund P, Nilsson S et al. Targeting of distinct signaling cascades and cancer-associated fibroblasts define the efficacy of Sorafenib against prostate cancer cells. Cell Death Dis 2012; 3:e262; PMID:22278289; http://dx.doi.org/ 10.1038/cddis.2012.1
17. Ostman A, Augsten M. Cancer-associated fibroblasts and tumor growth-bystanders turning into key players. Curr Opin Genet Dev 2009; 19:67-73; PMID:19211240; http://dx.doi.org/10.1016/j.gde.2009.01.003
18. Joyce JA, Pollard JW. Microenvironmental regulation of metastasis. Nat Rev Cancer 2009; 9:239-52; PMID:19279573; http://dx.doi.org/10.1038/nrc2618
19. Giannoni E, Bianchini F, Masieri L, Serni S, Torre E, Calorini L, Chiarugi P. Reciprocal activation of prostate cancer cells and cancer-associated fibroblasts stimulates epithelial-mesenchymal transition and cancer stemness. Cancer Res 2010; 70:6945-56; PMID:20699369; http://dx.doi.org/10.1158/0008-5472.CAN-10-0785
20. Zhang H, Maric I, DiPrima MJ, Khan J, Orentas RJ, Kaplan RN, Mackall CL. Fibrocytes represent a novel MDSC subset circulating in patients with metastatic cancer. Blood 2013; 122:1105-13; PMID:23757729; http://dx.doi.org/10.1182/blood-2012-08-449413
21. Talmadge JE, Gabrilovich DI. History of myeloidderived suppressor cells. Nat Rev Cancer 2013; 13:739-52; PMID:24060865; http://dx.doi.org/ 10.1038/nrc3581
22. Jitschin R, Braun M, Buttner M, Dettmer-Wilde K, Bricks J, Berger J, Eckart MJ, Krause SW, Oefner PJ, Le Blanc K et al. CLL-cells induce IDOhi CD14+HLADRlo myeloid derived suppressor cells that inhibit T-cell responses and promote TRegs. Blood 2014; 124(5):750-760; PMID:24850760; http://dx.doi.org/10.1182/ blood-2013-12-546416
23. Schirmer C, Klein C, von Bergen M, Simon JC, Saalbach A. Human fibroblasts support the expansion of IL-17-producing T cells via up-regulation of IL-23 production by dendritic cells. Blood 2010; 116:1715-25; PMID:20538798; http://dx.doi.org/10.1182/blood-2010-01-263509
24. Quan TE, Cowper SE, Bucala R. The role of circulating fibrocytes in fibrosis. Curr Rheumatol Rep 2006; 8:145-50; PMID:16569374; http://dx.doi.org/ 10.1007/s11926-006-0055-x
25. Reilkoff RA, Bucala R, Herzog EL. Fibrocytes: emerging effector cells in chronic inflammation. Nat Rev Immunol 2011; 11:427-35; PMID:21597472; http:// dx.doi.org/10.1038/nri2990
26. Shinde AV, Frangogiannis NG. Fibroblasts in myocardial infarction: a role in inflammation and repair. J Mol Cell Cardiol 2014; 70:74-82; PMID:24321195; http://dx.doi.org/10.1016/j.yjmcc.2013.11.015
27. Andersson-Sjoland A, de Alba CG, Nihlberg K, Becerril C, Ramirez R, Pardo A, Westergren-Thorsson G, Selman M. Fibrocytes are a potential source of lung fibroblasts in idiopathic pulmonary fibrosis. Int J Biochem Cell Biol 2008; 40:2129-40; PMID:18374622; http://dx.doi.org/10.1016/j.biocel.2008.02.012
28. OgawaM, LaRue AC,Drake CJ.Hematopoietic origin of fibroblasts/myofibroblasts: Its pathophysiologic implications. Blood 2006; 108:2893-6; PMID:16840726; http://dx.doi.org/10.1182/blood-2006-04-016600
29. Orimo A, Gupta PB, Sgroi DC, Arenzana-Seisdedos F, Delaunay T, Naeem R, Carey VJ, Richardson AL, Weinberg RA. Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell 2005; 121:335-48; PMID:15882617; http:// dx.doi.org/10.1016/j.cell.2005.02.034
30. Chesney J, Bacher M, Bender A, Bucala R. The peripheral blood fibrocyte is a potent antigen-presenting cell capable of priming naive T cells in situ. Proc Natl Acad Sci U S A 1997; 94:6307-12; PMID:9177213; http:// dx.doi.org/10.1073/pnas.94.12.6307
31. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub TR, Lander ES et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A 2005; 102:15545-50; PMID:16199517; http://dx. doi.org/10.1073/pnas.0506580102
32. Gotoh S, ItohM, Fujii Y, Arai S, Sendo F. Enhancement of the expression of a rat neutrophil-specific cell surface antigen by activation with phorbol myristate acetate and concanavalin A. J Immunol 1986; 137:643-50; PMID:2424975
33. Rhodes NP, Hunt JA, Williams DF. Macrophage subpopulation differentiation by stimulation with biomaterials. J Biomed Mater Res 1997; 37:481-8; PMID:9407296; http://dx.doi.org/10.1002/(SICI) 1097-4636(19971215)37:4%3c481::AIDJBM6% 3e3.0.CO;2-H
34. Pilling D, Fan T, Huang D, Kaul B, Gomer RH. Identification of markers that distinguish monocytederived fibrocytes from monocytes, macrophages, and fibroblasts. PloS One 2009; 4:e7475; PMID:19834619; http://dx.doi.org/10.1371/ journal.pone.0007475
35. Annacker O, Coombes JL, Malmstrom V, Uhlig HH, Bourne T, Johansson-Lindbom B, Agace WW, Parker CM, Powrie F. Essential role for CD103 in the T cellmediated regulation of experimental colitis. J Exp Med 2005; 202:1051-61; PMID:16216886; http://dx.doi. org/10.1084/jem.20040662
36. Munoz L, Jose Borrero M, Ubeda M, Lario M, Diaz D, Frances R,Monserrat J, Pastor O, Aguado-Fraile E, Such J et al. Interaction between intestinal dendritic cells and bacteria translocated from the gut in rats with cirrhosis. Hepatology 2012; 56:1861-9; PMID:22611024; http:// dx.doi.org/10.1002/hep.25854
37. Kraman M, Bambrough PJ, Arnold JN, Roberts EW, Magiera L, Jones JO, Gopinathan A, Tuveson DA, Fearon DT. Suppression of antitumor immunity by stromal cells expressing fibroblast activation protein-α. Science 2010; 330:827-30; PMID:21051638; http:// dx.doi.org/10.1126/science.1195300
38. Chang HY, Chi JT, Dudoit S, Bondre C, van de Rijn M, Botstein D, Brown PO. Diversity, topographic differentiation, and positionalmemory in human fibroblasts. ProcNatl Acad Sci U S A 2002; 99:12877-82; PMID:12297622; http://dx.doi.org/10.1073/pnas.162488599
39. Baglole CJ, Ray DM, Bernstein SH, Feldon SE, Smith TJ, Sime PJ, Phipps RP. More than structural cells, fibroblasts create and orchestrate the tumor microenvironment. Immunol Invest 2006; 35:297-325; PMID:16916756; http://dx. doi.org/10.1080/08820130600754960
40. Dimanche-Boitrel MT, Vakaet L Jr., Pujuguet P, Chauffert B, Martin MS, Hammann A, Van Roy F, Mareel M, Martin F. In vivo and in vitro invasiveness of a rat coloncancer cell line maintaining E-cadherin expression: an enhancing role of tumor-associated myofibroblasts. Int J Cancer 1994; 56:512-21; PMID:8112888; http://dx.doi. org/10.1002/ijc.2910560410
41. Gaggioli C, Hooper S, Hidalgo-Carcedo C, Grosse R, Marshall JF, Harrington K, Sahai E. Fibroblast-led collective invasion of carcinoma cells with differing roles for RhoGTPases in leading and following cells. Nat Cell Biol 2007; 9:1392-400; PMID:18037882; http:// dx.doi.org/10.1038/ncb1658
42. Ostrand-Rosenberg S. Animal models of tumor immunity, immunotherapy and cancer vaccines. Curr Opin Immunol 2004; 16:143-50; PMID:15023405; http:// dx.doi.org/10.1016/j.coi.2004.01.003
43. Vargo-Gogola T, Rosen JM. Modelling breast cancer: one size does not fit all. Nat Rev Cancer 2007; 7:659-72; PMID:17721431; http://dx.doi.org/10.1038/nrc2193
44. Singh M, McGinley JN, Thompson HJ. A comparison of the histopathology of premalignant and malignant mammary gland lesions induced in sexually immature rats with those occurring in the human. Lab Invest 2000; 80:221-31; PMID:10701691; http://dx.doi.org/ 10.1038/labinvest.3780025
45. Thompson HJ, Singh M. Rat models of premalignant breast disease. J Mammary Gland Biol Neoplasia 2000; 5:409-20; PMID:14973385; http://dx.doi.org/ 10.1023/A:1009582012493
46. Iannaccone PM, Jacob HJ. Rats! Dis Models Mech 2009; 2:206-10; PMID:19407324
47. Tirapu I, Huarte E, Guiducci C, Arina A, Zaratiegui M, Murillo O, Gonzalez A, Berasain C, Berraondo P, Fortes P et al. Low surface expression of B7-1 (CD80) is an immunoescape mechanism of colon carcinoma. Cancer Res 2006; 66:2442-50; PMID:16489051; http://dx.doi.org/10.1158/0008-5472.CAN-05-1681
48. Cheng HY, Ghetu N, Huang WC, Wang YL, Wallace CG, Wen CJ, Chen HC, Shih LY, Lin CF, Hwang SM et al. Syngeneic adipose-derived stem cells with shortterm immunosuppression induce vascularized composite allotransplantation tolerance in rats. Cytotherapy 2014; 16:369-80; PMID:24119648; http://dx.doi.org/ 10.1016/j.jcyt.2013.06.020
49. Furuhashi K, Tsuboi N, Shimizu A, Katsuno T, Kim H, Saka Y, Ozaki T, Sado Y, Imai E, Matsuo S et al. Serum-starved adipose-derived stromal cells ameliorate crescentic GN by promoting immunoregulatory macrophages. J Am Soc Nephrol 2013; 24:587-603; PMID:23471196; http://dx.doi.org/10.1681/ASN. 2012030264
50. Takeda Y, Marumo M, Wakabayashi I. Attenuated phagocytic activity of monocytes in type 2 diabetic Goto-Kakizaki rats. Immunobiology 2011; 216:1094-102; PMID:21652107; http://dx.doi.org/10.1016/j. imbio.2011.05.003
51. Thomas RA, Pietrzak DC, Scicchitano MS, Thomas HC, McFarland DC, Frazier KS. Detection and characterization of circulating endothelial progenitor cells in normal rat blood. J Pharmacol Toxicol Methods 2009; 60:263-74; PMID:19577656; http://dx.doi.org/ 10.1016/j.vascn.2009.06.002
52. Muehlbauer SM, Lima H Jr., Goldman DL, Jacobson LS, Rivera J, Goldberg MF, Palladino MA, Casadevall A, Brojatsch J. Proteasome inhibitors prevent caspase-1-mediated disease in rodents challenged with anthrax lethal toxin. Am J Pathol 2010; 177:735-43; PMID:20595632; http://dx.doi.org/10.2353/ajpath. 2010.090828
53. Mayer AM, Zhang P, Spitzer JA. Increased surface expression of CD11b/c and CD18 appears to be dissociated from anti-CD11b/c monoclonal antibody stimulated O2-anion generation in in vivo Escherichia coli lipopolysaccharide and tumor necrosis factor-α-treated rat neutrophils. Shock 1994; 2:289-95; PMID:7757523; http://dx.doi. org/10.1097/00024382-199410000-00010
54. Robinson AP, White TM, Mason DW. Macrophage heterogeneity in the rat as delineated by two monoclonal antibodies MRC OX-41 and MRC OX-42, the latter recognizing complement receptor type 3. Immunology 1986; 57:239-47; PMID:3512425
55. Yrlid U, Jenkins CD, MacPherson GG. Relationships between distinct blood monocyte subsets and migrating intestinal lymph dendritic cells in vivo under steady-state conditions. J Immunol 2006; 176:4155-62; PMID:165 47252; http://dx.doi.org/10.4049/jimmunol.176.7.4155
56. Badger DA, Sauer JM, Hoglen NC, Jolley CS, Sipes IG. The role of inflammatory cells and cytochrome P450 in the potentiation of CCl4-induced liver injury by a single dose of retinol. Toxicol Appl Pharmacol 1996; 141:507-19; PMID:8975775; http://dx.doi.org/ 10.1006/taap.1996.0316
57. Reckless J, Tatalick LM, Grainger DJ. The pan-chemokine inhibitor NR58-3.14.3 abolishes tumour necrosis factor-α accumulation and leucocyte recruitment induced by lipopolysaccharide in vivo. Immunology 2001; 103:244-54; PMID:11412312; http://dx.doi. org/10.1046/j.1365-2567.2001.01228.x
58. Wynn TA. Fibrotic disease and the T(H)1/T(H)2 paradigm. Nat Rev Immunol 2004; 4:583-94; PMID:15286725; http://dx.doi.org/10.1038/nri1412
59. Haniffa MA, Wang XN, Holtick U, Rae M, Isaacs JD, Dickinson AM, Hilkens CM, Collin MP. Adult human fibroblasts are potent immunoregulatory cells and functionally equivalent to mesenchymal stem cells. J Immunol 2007; 179:1595-604; PMID:17641026; http://dx. doi.org/10.4049/jimmunol.179.3.1595
60. Dugast AS, Haudebourg T, Coulon F, Heslan M, Haspot F, Poirier N, Vuillefroy de Silly R, Usal C, Smit H, Martinet B et al. Myeloid-derived suppressor cells accumulate in kidney allograft tolerance and specifically suppress effector T cell expansion. J Immunol 2008; 180:7898-906; PMID:18523253; http://dx.doi.org/ 10.4049/jimmunol.180.12.7898
61. Davis LS, Oppenheimer-Marks N, Bednarczyk JL, McIntyre BW, Lipsky PE. Fibronectin promotes proliferation of naive and memory T cells by signaling through both the VLA-4 and VLA-5 integrin molecules. J Immunol 1990; 145:785-93; PMID:1695644
62. Jones S, Horwood N, Cope A, Dazzi F. The antiproliferative effect of mesenchymal stem cells is a fundamental property shared by all stromal cells. J Immunol 2007; 179:2824-31; PMID:17709496; http://dx.doi. org/10.4049/jimmunol.179.5.2824
63. Pinchuk IV, Saada JI, Beswick EJ, Boya G, Qiu SM, Mifflin RC, Raju GS, Reyes VE, Powell DW. PD-1 ligand expression by human colonic myofibroblasts/ fibroblasts regulates CD4+ T-cell activity. Gastroenterology 2008; 135:1228-37, 37 e1-2; PMID:18760278; http://dx.doi.org/10.1053/j.gastro.2008.07.016
64. Macejova D, Brtko J. Chemically induced carcinogenesis: a comparison of 1-methyl-1-nitrosourea, 7,12-dimethylbenzanthracene,diethylnitroso-amine and azoxymethan models (minireview). Endocr Regul 2001; 35:53-9; PMID:11308997
65. Fazzino F, Obregon F, Lima L. Taurine and proliferation of lymphocytes in physically restrained rats. J Biomed Sci 2010; 17 Suppl 1:S24; PMID:20804599; http://dx.doi.org/10.1186/1423-0127-17-S1-S24
66. Lyons AB. Analysing cell division in vivo and in vitro using flow cytometric measurement of CFSE dye dilution. J Immunol Methods 2000; 243:147-54; PMID:10986412; http://dx.doi.org/10.1016/S0022-1759(00)00231-3
67. Barrett T, Wilhite SE, Ledoux P, Evangelista C, Kim IF, Tomashevsky M, Marshall KA, Phillippy KH, Sherman PM, Holko M et al. NCBI GEO: archive for functional genomics data sets-update. Nucleic Acids Res 2013; 41:D991-5; PMID:23193258; http://dx. doi.org/10.1093/nar/gks1193
68. Walter K, Omura N, Hong SM, Griffith M, Vincent A, Borges M, Goggins M. Overexpression of smoothened activates the sonic hedgehog signaling pathway in pancreatic cancer-associated fibroblasts. Clin Cancer Res 2010; 16:1781-9; PMID:20215540; http://dx.doi. org/10.1158/1078-0432.CCR-09-1913
69. Davis S, Meltzer PS. GEOquery: a bridge between the Gene Expression Omnibus (GEO) and BioConductor. Bioinformatics 2007; 23:1846-7; PMID:17496320; http://dx.doi.org/10.1093/bioinformatics/btm254
70. Carvalho BS, Irizarry RA. A framework for oligonucleotide microarray preprocessing. Bioinformatics 2010; 26:2363-7; PMID:20688976; http://dx.doi.org/ 10.1093/bioinformatics/btq431
71. Smyth GK. Limma: linear models for microarray data. In: Gentleman R, Carey V, Dudoit S, Irizarry R, Huber W, eds. Bioinformatics and Computational Biology Solutions Using R and Bioconductor. New York: Springer, 2005:397-420; http://dx.doi.org/10.1007/0-387-29362-0
72. Ihaka R, Gentleman R. R: a language for data analysis and graphics. J Comput Graphic Stat 1996; 5:299-314; http://dx.doi.org/10.1080/10618600.1996.10474713
73. Gentleman RC, Carey VJ, Bates DM, Bolstad B, Dettling M, Dudoit S, Ellis B, Gautier L, Ge Y, Gentry J et al. Bioconductor: open software development for computational biology and bioinformatics. Genome Biol 2004; 5:R80; PMID:15461798; http://dx.doi.org/ 10.1186/gb-2004-5-10-r80
74. Kelly-Welch AE, Hanson EM, Boothby MR, Keegan AD. Interleukin-4 and interleukin-13 signaling connections maps. Science 2003; 300:1527-8; PMID:12791978; http://dx.doi.org/10.1126/science.1085458
75. Saunders B, Lyon S, DayM, Riley B, Chenette E, Subramaniam S, Vadivelu I. The molecule pages database. Nucleic Acids Res 2008; 36:D700-6; PMID:17965093; http://dx.doi.org/10.1093/nar/gkm907
76. Miller CC, Godeau G, Lebreton-DeCoster C, Desmouliere A, Pellat B, Dubertret L, Coulomb B. Validation of a morphometric method for evaluating fibroblast numbers in normal and pathologic tissues. Exp Dermatol 2003; 12:403-11; PMID:12930296; http://dx.doi.org/10.1034/j.1600-0625.2003.00023.x
77. De LKT, Whiting CV, Bland PW. Proinflammatory cytokine synthesis by mucosal fibroblasts from mouse colitis is enhanced by interferon-gamma-mediated upregulation of CD40 signalling. Clin Exp Immunol 2007; 147:313-23; PMID:17223973
78. Boquest AC, Day BN, Prather RS. Flow cytometric cell cycle analysis of cultured porcine fetal fibroblast cells. Biol Reprod 1999; 60:1013-9; PMID:10084979; http://dx.doi.org/10.1095/biolreprod60.4.1013
79. Aslakson CJ, Miller FR. Selective events in the metastatic process defined by analysis of the sequential dissemination of subpopulations of a mouse mammary tumor. Cancer Res 1992; 52:1399-405;PMID:1540948